Oxycodone (Oxycodone Amneal) 10 and 20 mg tabs immediate release tablets: Supply issue

Supply issue Active

There are supply issues affecting the 10 mg and 20 mg immediate release oxycodone tablets.

9 May 2025 | Update

Resupply of the 10 mg and 20 mg has been delayed until early June 2025, due to shipping issues.

Affected products

There are supply issues affecting oxycodone hydrochloride

  • Presentation: Tab immediate-release 10 mg
    • Brand: Oxycodone Amneal
    • Pharmacode: 2681927 and 2696061
    • Subsidy: $18.77
    • Measure / Qty: per 100
  • Presentation: Tab immediate-release 20 mg
    • Brand: Oxycodone Amneal
    • Pharmacode: 2681935 and 2696088
    • Subsidy: $26.77
    • Measure / Qty: per 100

Schedule listing for oxycodone(external link)

Alternative product

The 5 mg tablets are available. Rule 3.4.2 applies for funding, however a new prescription may be needed to meet requirements of the Misuse of Drugs Regulations.

Supply of the oral liquid is now also constrained.

Prescribers may also want to consider prescribing an alternative analgesic.

BPAC Practice information: Revisiting opioid use in New Zealand: how does your prescribing compare?(external link)

We acknowledge that this will cause create disruption for those affected. We have developed a flyer to support conversations with people affected by this supply issue.

Expected resupply

The 10 and 20 mg tablets are expected to arrive by early June 2025.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)